Regulation of G0-G1 Transition in Hepatocytes

肝细胞 G0-G1 转变的调节

基本信息

  • 批准号:
    7142463
  • 负责人:
  • 金额:
    $ 20.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-07-10 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): During liver regeneration, quiescent hepatocytes reenter the cell cycle, proliferate and repopulate the diseased liver. This process is observed in many forms of acute liver injury specifically those caused by viruses, toxins and trauma. Therefore, prognosis in acute liver failure often depends on the ability of proliferation to outlast liver cell necrosis. The long-term objective of the studies outlined here is to use recent knowledge of events that regulate exit from quiescence to identify liver specific targets in the initiation of liver regeneration. The first aim of the study is to evaluate for novel cyclin dependent kinase activities that regulate the transition from quiescence to active cell cycling. We believe that cyclin dependent kinase activities that precede the canonical G1 cyclins are important in transiting from G0 to G1 during the regenerative process. The second aim of the study is to design a siRNA based screen that targets genes up regulated in the priming phase of liver regeneration. The goal is to identify genes whose products are necessary for cycle progression. Our hope is to identify physiologically relevant molecules that can be therapeutic targets for enhancement of liver proliferation. A cell based assay using H35 rat liver cell line, which can undergo the transition from quiescence to cell cycle reentry, will be used for both lines of inquiry.
描述(由申请方提供):在肝再生期间,静止肝细胞重新进入细胞周期,增殖并重新填充患病肝脏。这个过程在许多形式的急性肝损伤中都可以观察到,特别是由病毒、毒素和创伤引起的急性肝损伤。因此,急性肝功能衰竭的预后通常取决于增殖超过肝细胞坏死的能力。这里概述的研究的长期目标是利用最近的知识,调节退出静止的事件,以确定肝再生启动的肝脏特异性靶点。本研究的第一个目的是评估新的细胞周期蛋白依赖性激酶活性,调节从静止到活跃的细胞周期的过渡。我们认为,细胞周期蛋白依赖性激酶的活动之前,典型的G1期细胞周期蛋白是重要的G0过渡到G1在再生过程中。该研究的第二个目的是设计一种基于siRNA的筛选,其靶向在肝再生的启动阶段上调的基因。目标是确定其产物是周期进展所必需的基因。我们的希望是确定生理相关的分子,可以作为治疗靶点,以增强肝脏增殖。使用H35大鼠肝细胞系进行的基于细胞的测定将用于这两条研究线,该细胞系可以经历从静止到细胞周期重新进入的转变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Chinweike Ukomadu其他文献

Chinweike Ukomadu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Chinweike Ukomadu', 18)}}的其他基金

Regulation of G0-G1 Transition in Hepatocytes
肝细胞 G0-G1 转变的调节
  • 批准号:
    7267960
  • 财政年份:
    2006
  • 资助金额:
    $ 20.19万
  • 项目类别:
Cell cycle block by HMG co-A reductase inhibitors
HMG co-A 还原酶抑制剂阻断细胞周期
  • 批准号:
    7252472
  • 财政年份:
    2003
  • 资助金额:
    $ 20.19万
  • 项目类别:
Cell cycle block by HMG co-A reductase inhibitors
HMG co-A 还原酶抑制剂阻断细胞周期
  • 批准号:
    6902585
  • 财政年份:
    2003
  • 资助金额:
    $ 20.19万
  • 项目类别:
Cell cycle block by HMG co-A reductase inhibitors
HMG co-A 还原酶抑制剂阻断细胞周期
  • 批准号:
    6801016
  • 财政年份:
    2003
  • 资助金额:
    $ 20.19万
  • 项目类别:
Cell cycle block by HMG co-A reductase inhibitors
HMG co-A 还原酶抑制剂阻断细胞周期
  • 批准号:
    6685365
  • 财政年份:
    2003
  • 资助金额:
    $ 20.19万
  • 项目类别:
Cell cycle block by HMG co-A reductase inhibitors
HMG co-A 还原酶抑制剂阻断细胞周期
  • 批准号:
    7073413
  • 财政年份:
    2003
  • 资助金额:
    $ 20.19万
  • 项目类别:

相似海外基金

Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
  • 批准号:
    23K06731
  • 财政年份:
    2023
  • 资助金额:
    $ 20.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
  • 批准号:
    23K06616
  • 财政年份:
    2023
  • 资助金额:
    $ 20.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
  • 批准号:
    10597799
  • 财政年份:
    2023
  • 资助金额:
    $ 20.19万
  • 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
  • 批准号:
    EP/Y024591/1
  • 财政年份:
    2023
  • 资助金额:
    $ 20.19万
  • 项目类别:
    Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10672364
  • 财政年份:
    2022
  • 资助金额:
    $ 20.19万
  • 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
  • 批准号:
    10385037
  • 财政年份:
    2022
  • 资助金额:
    $ 20.19万
  • 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
  • 批准号:
    10383462
  • 财政年份:
    2022
  • 资助金额:
    $ 20.19万
  • 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
  • 批准号:
    10483063
  • 财政年份:
    2022
  • 资助金额:
    $ 20.19万
  • 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10546865
  • 财政年份:
    2022
  • 资助金额:
    $ 20.19万
  • 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
  • 批准号:
    2752732
  • 财政年份:
    2022
  • 资助金额:
    $ 20.19万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了